Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamma-irradiated BCG vaccination in human endotoxemia and endotoxin tolerance
NL-OMON40604Phase 3Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gamma-irradiated bacillus calmette-guérin vaccine in sepsis and Bacteremia (4 arms), sponsored by Radboud University Medical Center. Primary endpoints: Single endotoxemia primary endpoint and Repeated endotoxemia primary endpoint. Started Apr 2014; status: active, not recruiting.
02
Drugs
gamma-irradiated bacillus calmette-guérin vaccine
03
Conditions
sepsisBacteremia
Beyond the preview
Go deeper on NL-OMON40604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40604.